5 Key Takeaways
-
1
Two-thirds of patients with neovascular age-related macular degeneration reduced anti-VEGF injections after epiretinal membrane removal.
-
2
The study involved 12 patients who underwent pars plana vitrectomy with epiretinal membrane removal.
-
3
The mean number of anti-VEGF injections decreased from 7.58 to 4.33 after surgery (P=.009).
-
4
Central retinal thickness decreased from approximately 328 μm to 288 μm post-surgery, but the change was not statistically significant (P=.092).
-
5
The study's limitations include a small sample size and treatment by a single provider at one site.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.